Sequential cytarabine and alpha-particle immunotherapy with bismuth-213 ((213)Bi)-labeled-HuM195 (lintuzumab) for acute myeloid leukemia (AML) Meeting Abstract

  


Authors: Rosenblat, T.; McDevitt, M. R.; Mulford, D. A.; Pandit-Taskar, N.; Weiss, M. A.; Heaney, M. L.; Chanel, S.; Morgenstern, A.; Larson, S. M.; Scheinberg, D. A.; Jurcic, J. G.
Abstract Title: Sequential cytarabine and alpha-particle immunotherapy with bismuth-213 ((213)Bi)-labeled-HuM195 (lintuzumab) for acute myeloid leukemia (AML)
Meeting Title: 50th Annual Meeting of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 112
Issue: 11
Meeting Dates: 2008 Dec 6-9
Meeting Location: San Francisco, CA
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2008-11-16
Start Page: 1025
Language: English
ACCESSION: WOS:000262104703420
PROVIDER: wos
PUBMED: 22276298
DOI: 10.1182/blood.V112.11.2983.2983
Notes: --- - Meeting Abstract: 2983 - Poster Session - 50th Annual Meeting of the American-Society-of-Hematology - DEC 06-09, 2008 - San Francisco, CA - "Source: Wos"
Altmetric
What is Altmetric?
Citation Impact
What is Dimensions Citation Badge?
BMJ Impact Analytics
MSK Authors
  1. Deborah Mulford
    8 Mulford
  2. Mark L Heaney
    94 Heaney
  3. Michael R Mcdevitt
    144 Mcdevitt
  4. Joseph G Jurcic
    134 Jurcic
  5. Neeta Pandit-Taskar
    342 Pandit-Taskar
  6. Suzanne M Chanel
    31 Chanel
  7. David Scheinberg
    499 Scheinberg
  8. Todd Louis Rosenblat
    21 Rosenblat
  9. Steven M Larson
    958 Larson
  10. Mark Weiss
    86 Weiss
Related MSK Work